Article
Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacy
2024-08-08
Abstract excerpt
<title>Abstract</title> <p>Lipid nanoparticles (LNPs) are the most clinically relevant vehicles for mRNA vaccines. Despite the great successes, the toxicity caused by the high dose of lipid components still represents a great challenge. The suboptimal loading efficiency of mRNA in LNPs not only compromises the vaccine’s efficacy but also heightens the risk of non-specific immune responses, accelerates clearance f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 51bb3389-14e4-5667-830a-05b39a94864e
- DOI
- 10.21203/rs.3.rs-4755456/v1
